Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
27
FSPKF Quote, Financials, Valuation and Earnings
Last price:
$19.26
Seasonality move
:
3.76%
Day range:
$19.26 - $19.26
52-week range:
$16.35 - $25.91
Dividend yield:
1.81%
P/E ratio:
44.45x
P/S ratio:
8.91x
P/B ratio:
101.80x
Volume:
92
Avg. volume:
110
1-year change:
-4.65%
Market cap:
$11.3B
Revenue:
$1.2B
EPS (TTM):
$0.43
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
-- | -- | -- | -- | -- |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- |
|
CVM
CEL-SCI Corp.
|
-- | -- | -- | -- | $42.50 |
|
PFGTF
Pacific Edge Ltd.
|
-- | -- | -- | -- | -- |
|
RHCGF
Ryman Healthcare Ltd.
|
-- | -- | -- | -- | -- |
|
SMGRF
Summerset Group Holdings Ltd.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
$19.26 | -- | $11.3B | 44.45x | $0.17 | 1.81% | 8.91x |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
CVM
CEL-SCI Corp.
|
$5.19 | $42.50 | $15.7M | -- | $0.00 | 0% | -- |
|
PFGTF
Pacific Edge Ltd.
|
$0.08 | -- | $81.8M | -- | $0.00 | 0% | 6.84x |
|
RHCGF
Ryman Healthcare Ltd.
|
$1.75 | -- | $875M | -- | $0.00 | 0% | 3.38x |
|
SMGRF
Summerset Group Holdings Ltd.
|
$7.20 | -- | $1.7B | 7.89x | $0.07 | 1.95% | 8.52x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
3.28% | 0.499 | -- | 1.14x |
|
AROAF
Aroa Biosurgery
|
-- | 0.000 | -- | -- |
|
CVM
CEL-SCI Corp.
|
37.03% | 1.679 | 33.61% | 2.14x |
|
PFGTF
Pacific Edge Ltd.
|
1.14% | -3.720 | -- | 2.82x |
|
RHCGF
Ryman Healthcare Ltd.
|
-- | 1.726 | -- | -- |
|
SMGRF
Summerset Group Holdings Ltd.
|
36.6% | -0.055 | -- | 0.11x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
$299.7M | -$209.7M | 18.6% | 19.71% | 40.18% | -- |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- | -- |
|
CVM
CEL-SCI Corp.
|
-$960.8K | -$6M | -117.93% | -230.36% | -- | -$4.7M |
|
PFGTF
Pacific Edge Ltd.
|
-- | -- | -69.68% | -72.02% | -- | -- |
|
RHCGF
Ryman Healthcare Ltd.
|
-- | -- | -- | -- | -- | -- |
|
SMGRF
Summerset Group Holdings Ltd.
|
-- | -- | 5.8% | 12.83% | -- | -- |
Fisher & Paykel Healthcare Corp. Ltd. vs. Competitors
-
Which has Higher Returns FSPKF or AROAF?
Aroa Biosurgery has a net margin of 29.46% compared to Fisher & Paykel Healthcare Corp. Ltd.'s net margin of --. Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71% beat Aroa Biosurgery's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B AROAFAroa Biosurgery-- -- -- -
What do Analysts Say About FSPKF or AROAF?
Fisher & Paykel Healthcare Corp. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Aroa Biosurgery has an analysts' consensus of -- which suggests that it could fall by --. Given that Fisher & Paykel Healthcare Corp. Ltd. has higher upside potential than Aroa Biosurgery, analysts believe Fisher & Paykel Healthcare Corp. Ltd. is more attractive than Aroa Biosurgery.
Company Buy Ratings Hold Ratings Sell Ratings FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 AROAFAroa Biosurgery0 0 0 -
Is FSPKF or AROAF More Risky?
Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.201, which suggesting that the stock is 20.107% more volatile than S&P 500. In comparison Aroa Biosurgery has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock FSPKF or AROAF?
Fisher & Paykel Healthcare Corp. Ltd. has a quarterly dividend of $0.17 per share corresponding to a yield of 1.81%. Aroa Biosurgery offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fisher & Paykel Healthcare Corp. Ltd. pays 77.61% of its earnings as a dividend. Aroa Biosurgery pays out -- of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FSPKF or AROAF?
Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues are $723.8M, which are larger than Aroa Biosurgery quarterly revenues of --. Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M is higher than Aroa Biosurgery's net income of --. Notably, Fisher & Paykel Healthcare Corp. Ltd.'s price-to-earnings ratio is 44.45x while Aroa Biosurgery's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fisher & Paykel Healthcare Corp. Ltd. is 8.91x versus -- for Aroa Biosurgery. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FSPKFFisher & Paykel Healthcare Corp. Ltd.8.91x 44.45x $723.8M $213.2M AROAFAroa Biosurgery-- -- -- --
-
Which has Higher Returns FSPKF or CVM?
CEL-SCI Corp. has a net margin of 29.46% compared to Fisher & Paykel Healthcare Corp. Ltd.'s net margin of --. Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71% beat CEL-SCI Corp.'s return on equity of -230.36%.
Company Gross Margin Earnings Per Share Invested Capital FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B CVMCEL-SCI Corp.-- -$0.76 $25.3M -
What do Analysts Say About FSPKF or CVM?
Fisher & Paykel Healthcare Corp. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand CEL-SCI Corp. has an analysts' consensus of $42.50 which suggests that it could grow by 718.88%. Given that CEL-SCI Corp. has higher upside potential than Fisher & Paykel Healthcare Corp. Ltd., analysts believe CEL-SCI Corp. is more attractive than Fisher & Paykel Healthcare Corp. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 CVMCEL-SCI Corp.1 0 0 -
Is FSPKF or CVM More Risky?
Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.201, which suggesting that the stock is 20.107% more volatile than S&P 500. In comparison CEL-SCI Corp. has a beta of 0.487, suggesting its less volatile than the S&P 500 by 51.259%.
-
Which is a Better Dividend Stock FSPKF or CVM?
Fisher & Paykel Healthcare Corp. Ltd. has a quarterly dividend of $0.17 per share corresponding to a yield of 1.81%. CEL-SCI Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fisher & Paykel Healthcare Corp. Ltd. pays 77.61% of its earnings as a dividend. CEL-SCI Corp. pays out -- of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FSPKF or CVM?
Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues are $723.8M, which are larger than CEL-SCI Corp. quarterly revenues of --. Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M is higher than CEL-SCI Corp.'s net income of -$6.1M. Notably, Fisher & Paykel Healthcare Corp. Ltd.'s price-to-earnings ratio is 44.45x while CEL-SCI Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fisher & Paykel Healthcare Corp. Ltd. is 8.91x versus -- for CEL-SCI Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FSPKFFisher & Paykel Healthcare Corp. Ltd.8.91x 44.45x $723.8M $213.2M CVMCEL-SCI Corp.-- -- -- -$6.1M
-
Which has Higher Returns FSPKF or PFGTF?
Pacific Edge Ltd. has a net margin of 29.46% compared to Fisher & Paykel Healthcare Corp. Ltd.'s net margin of --. Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71% beat Pacific Edge Ltd.'s return on equity of -72.02%.
Company Gross Margin Earnings Per Share Invested Capital FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B PFGTFPacific Edge Ltd.-- -- $15.1M -
What do Analysts Say About FSPKF or PFGTF?
Fisher & Paykel Healthcare Corp. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Pacific Edge Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Fisher & Paykel Healthcare Corp. Ltd. has higher upside potential than Pacific Edge Ltd., analysts believe Fisher & Paykel Healthcare Corp. Ltd. is more attractive than Pacific Edge Ltd..
Company Buy Ratings Hold Ratings Sell Ratings FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 PFGTFPacific Edge Ltd.0 0 0 -
Is FSPKF or PFGTF More Risky?
Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.201, which suggesting that the stock is 20.107% more volatile than S&P 500. In comparison Pacific Edge Ltd. has a beta of -3.301, suggesting its less volatile than the S&P 500 by 430.112%.
-
Which is a Better Dividend Stock FSPKF or PFGTF?
Fisher & Paykel Healthcare Corp. Ltd. has a quarterly dividend of $0.17 per share corresponding to a yield of 1.81%. Pacific Edge Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fisher & Paykel Healthcare Corp. Ltd. pays 77.61% of its earnings as a dividend. Pacific Edge Ltd. pays out -- of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FSPKF or PFGTF?
Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues are $723.8M, which are larger than Pacific Edge Ltd. quarterly revenues of --. Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M is higher than Pacific Edge Ltd.'s net income of --. Notably, Fisher & Paykel Healthcare Corp. Ltd.'s price-to-earnings ratio is 44.45x while Pacific Edge Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fisher & Paykel Healthcare Corp. Ltd. is 8.91x versus 6.84x for Pacific Edge Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FSPKFFisher & Paykel Healthcare Corp. Ltd.8.91x 44.45x $723.8M $213.2M PFGTFPacific Edge Ltd.6.84x -- -- --
-
Which has Higher Returns FSPKF or RHCGF?
Ryman Healthcare Ltd. has a net margin of 29.46% compared to Fisher & Paykel Healthcare Corp. Ltd.'s net margin of --. Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71% beat Ryman Healthcare Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B RHCGFRyman Healthcare Ltd.-- -- -- -
What do Analysts Say About FSPKF or RHCGF?
Fisher & Paykel Healthcare Corp. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Ryman Healthcare Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Fisher & Paykel Healthcare Corp. Ltd. has higher upside potential than Ryman Healthcare Ltd., analysts believe Fisher & Paykel Healthcare Corp. Ltd. is more attractive than Ryman Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 RHCGFRyman Healthcare Ltd.0 0 0 -
Is FSPKF or RHCGF More Risky?
Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.201, which suggesting that the stock is 20.107% more volatile than S&P 500. In comparison Ryman Healthcare Ltd. has a beta of 0.512, suggesting its less volatile than the S&P 500 by 48.843%.
-
Which is a Better Dividend Stock FSPKF or RHCGF?
Fisher & Paykel Healthcare Corp. Ltd. has a quarterly dividend of $0.17 per share corresponding to a yield of 1.81%. Ryman Healthcare Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fisher & Paykel Healthcare Corp. Ltd. pays 77.61% of its earnings as a dividend. Ryman Healthcare Ltd. pays out -- of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FSPKF or RHCGF?
Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues are $723.8M, which are larger than Ryman Healthcare Ltd. quarterly revenues of --. Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M is higher than Ryman Healthcare Ltd.'s net income of --. Notably, Fisher & Paykel Healthcare Corp. Ltd.'s price-to-earnings ratio is 44.45x while Ryman Healthcare Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fisher & Paykel Healthcare Corp. Ltd. is 8.91x versus 3.38x for Ryman Healthcare Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FSPKFFisher & Paykel Healthcare Corp. Ltd.8.91x 44.45x $723.8M $213.2M RHCGFRyman Healthcare Ltd.3.38x -- -- --
-
Which has Higher Returns FSPKF or SMGRF?
Summerset Group Holdings Ltd. has a net margin of 29.46% compared to Fisher & Paykel Healthcare Corp. Ltd.'s net margin of --. Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71% beat Summerset Group Holdings Ltd.'s return on equity of 12.83%.
Company Gross Margin Earnings Per Share Invested Capital FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B SMGRFSummerset Group Holdings Ltd.-- -- $2.6B -
What do Analysts Say About FSPKF or SMGRF?
Fisher & Paykel Healthcare Corp. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Summerset Group Holdings Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Fisher & Paykel Healthcare Corp. Ltd. has higher upside potential than Summerset Group Holdings Ltd., analysts believe Fisher & Paykel Healthcare Corp. Ltd. is more attractive than Summerset Group Holdings Ltd..
Company Buy Ratings Hold Ratings Sell Ratings FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 SMGRFSummerset Group Holdings Ltd.0 0 0 -
Is FSPKF or SMGRF More Risky?
Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.201, which suggesting that the stock is 20.107% more volatile than S&P 500. In comparison Summerset Group Holdings Ltd. has a beta of -0.437, suggesting its less volatile than the S&P 500 by 143.654%.
-
Which is a Better Dividend Stock FSPKF or SMGRF?
Fisher & Paykel Healthcare Corp. Ltd. has a quarterly dividend of $0.17 per share corresponding to a yield of 1.81%. Summerset Group Holdings Ltd. offers a yield of 1.95% to investors and pays a quarterly dividend of $0.07 per share. Fisher & Paykel Healthcare Corp. Ltd. pays 77.61% of its earnings as a dividend. Summerset Group Holdings Ltd. pays out 16.94% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FSPKF or SMGRF?
Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues are $723.8M, which are larger than Summerset Group Holdings Ltd. quarterly revenues of --. Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M is higher than Summerset Group Holdings Ltd.'s net income of --. Notably, Fisher & Paykel Healthcare Corp. Ltd.'s price-to-earnings ratio is 44.45x while Summerset Group Holdings Ltd.'s PE ratio is 7.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fisher & Paykel Healthcare Corp. Ltd. is 8.91x versus 8.52x for Summerset Group Holdings Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FSPKFFisher & Paykel Healthcare Corp. Ltd.8.91x 44.45x $723.8M $213.2M SMGRFSummerset Group Holdings Ltd.8.52x 7.89x -- --
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
14
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 40.26% over the past day.
Buy
71
ZCSH alert for Dec 30
Grayscale Zcash Trust (ZEC) [ZCSH] is down 4.56% over the past day.
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 3.19% over the past day.
